论文部分内容阅读
Ferumoxytol,an iron replacement product in clinic practices,is an agent of superparamagnetic iron oxide nanoparticles coated with polyglucose sorbitol carboxymethylether.It is approved for the intravenous therapy of iron deficiency anemia in patients with chronic kidney disease.Compared with oral iron therapy which is poorly tolerated in many patients with gastrointestinal disorders,ferumoxytol has been considered as an efficacious and well-tolerated option for these patients[1].Besides of the
Ferumoxytol, an iron replacement product in clinic practices, is an agent of superparamagnetic iron oxide nanoparticles coated with polyglucose sorbitol carboxymethylether. It is approved for the intravenous therapy of iron deficiency anemia in patients with chronic kidney disease. Compared with oral iron therapy which is poorly tolerated in many patients with gastrointestinal disorders, ferumoxytol has been considered as an efficacious and well-tolerated option for these patients [1] .Besides of the